BTN3A1 and cancer: The human BTN2A1, BTN3A1, BTN3A2, and BTN3A3 are emerging as key regulators of non-conventional Vγ9Vδ2 T cells, which are important effectors against selected microbial infections and cancers and have been shown to correlate with improved patient outcome when infiltrating tumoral tissue (73–85).